Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective

@article{Schuetz2015EconomicEO,
  title={Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective},
  author={Philipp Schuetz and Robert A. Balk and Matthias Briel and Alexander Kutz and Mirjam Christ-Crain and Daiana Stolz and Lila Bouadma and Michel Wolff and Kristina B. Kristoffersen and Long Wei and Olaf Dr Burkhardt and Tobias Welte and Stefan Schroeder and Vandack Nobre and Michael Tamm and Neera Bhatnagar and Heiner C. Bucher and Charles-Edouard Luyt and Jean Chastre and Florence Tubach and Beat Mueller and Michael J. Lacey and Robert L. Ohsfeldt and Cara M. Scheibling and John E. Schneider},
  journal={Clinical Chemistry and Laboratory Medicine (CCLM)},
  year={2015},
  volume={53},
  pages={583 - 592}
}
Abstract Background: Whether or not antibiotic stewardship protocols based on procalcitonin levels results in cost savings remains unclear. Herein, our objective was to assess the economic impact of adopting procalcitonin testing among patients with suspected acute respiratory tract infection (ARI) from the perspective of a typical US integrated delivery network (IDN) with a 1,000,000 member catchment area or enrollment. Methods: To conduct an economic evaluation of procalcitonin testing versus… 

Figures and Tables from this paper

Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective
TLDR
Substantial savings are associated with PCT protocols of ARI across common China hospital treatment settings mainly by direct reduction in unnecessary antibiotic utilization.
The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis
TLDR
Using a Procalcitonin-algorithm to guide antibiotic use in sepsis and hospitalised lower respiratory tract infection patients is expected to generate cost-savings to the hospital and lower rates of antibiotic resistance and C.difficile infections.
Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis
TLDR
An individual patient data meta-analysis on the effects of PCT guided antibiotic therapy in upper respiratory tract infections (URTI) found it was associated with reduced antibiotic exposure in URTI patients without compromising outcomes.
Is Procalcitonin Biomarker-Guided Antibiotic Therapy a Cost-Effective Approach to Reduce Antibiotic Resistant and Clostridium difficile Infections in Hospitalized Patients?
TLDR
A PCT biomarker-guided antibiotic management strategy is likely to reduce the number of ABR and CDI cases and generate cost savings in a population of patients hospitalized with suspected sepsis or with a COPD exacerbation.
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
TLDR
The safety and efficacy of using procalcitonin for starting or stopping antibiotics over a large range of patients with varying severity of ARIs and from different clinical settings was assessed.
Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study
TLDR
PCT may offer a more tailor-made treatment to the individual ED patient with fever and the economic consequences of implementing PCT-guided therapy in the ED are revealed.
Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data
TLDR
It is found that health care with the PCT decision algorithm for ABS in sepsis and LRTI patients resulted in shorter length of stay, reduced antibiotic use, fewer mechanical ventilation days, and lower numbers of patients with C. difficile and ABR infections.
Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
TLDR
Clinical effectiveness and cost-effectiveness of adding PCT testing to the information used to guide antibiotic therapy in adults and children with confirmed or highly suspected sepsis in intensive care and presenting to the emergency department (ED) with suspected bacterial infection are assessed.
Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
TLDR
In this real-world analysis of inpatients with AECOPD, PCT-guided therapy was poorly adopted by providers and was not associated with a decrease in total antibiotic DOT, however, a low PCT level was associated with an increase in comfort stepping down from IV to PO therapy.
...
...

References

SHOWING 1-10 OF 104 REFERENCES
Procalcitonin for reduced antibiotic exposure in the critical care setting: A systematic review and an economic evaluation*
TLDR
Procalcitonin-guided antibiotic therapy is associated with a reduction in antibiotic usage that, under certain assumptions, may reduce overall costs of care, and the overall estimate cannot rule out a 7% increase in hospital mortality.
Cost-Effectiveness of Procalcitonin-Guided Antibiotic Therapy for Outpatient Management of Acute Respiratory Tract Infections in Adults
TLDR
Procalcitonin-guided antibiotic therapy for outpatient management of ARTIs in adults would be cost-effective when the costs of antibiotic resistance are considered and procalCitonin testing is limited to adults with ARTIs judged by their physicians to require antibiotics.
Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
TLDR
This study validates previous results from controlled trials in real-life conditions and demonstrates that following a PCT algorithm effectively reduces antibiotic use without increasing the risk of complications.
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
TLDR
The safety and efficacy of using procalcitonin for starting or stopping antibiotics over a large range of patients with varying severity of ARIs and from different clinical settings was assessed.
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
TLDR
Compliance with PCT-guided antibiotic stewardship was affected by geographically and culturally-influenced subjective clinical judgment and Initiation of antibiotic therapy was altered by PCT levels.
Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]
TLDR
The aim of this trial is to compare a ProCT-guided antibiotic therapy with a standard approach based on evidence-based guidelines for patients with ARTI in primary care with an open intervention.
Effect of Introducing Procalcitonin on Antimicrobial Therapy Duration in Patients With Sepsis and/or Pneumonia in the Intensive Care Unit
TLDR
Introducing procalcitonin levels at a teaching hospital resulted in a shorter duration of initial antimicrobial therapy and was not associated with adverse treatment outcomes.
Cost-Effectiveness of Procalcitonin-Guided Antibiotic Use in Community Acquired Pneumonia
TLDR
Procalcitonin protocol use in hospitalized CAP patients, although promising, lacks physician nonadherence and resource use data in routine care settings, which are needed to evaluate its potential role in patient care.
Effect of Procalcitonin-Guided Treatment in Patients with Infections: a Systematic Review and Meta-Analysis
TLDR
PCT-guided antibiotic treatment appears to be safe and may also improve clinical outcome, and an algorithm based on serial PCT measurements would allow a more judicious use of antibiotics than currently occurs during the traditional treatment of patients with infections.
Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
TLDR
As an adjunct to guidelines, procalcitonin-guided therapy markedly reduces antibiotic use for acute respiratory tract infections in primary care without compromising patient outcome.
...
...